“…These fungicides have specific single-site mode of action, thus they are active at one point of one metabolic pathway of the pathogen, and therefore are generally more at-risk for resistance development than other fungicides (McGrath, 2001). Several reports have been published about the appearance and increase of CPM populations (mainly Px) resistant to six groups of single-site inhibitors (benzimidazole, DMI, morpholine, hydroxypyrimidine, phosphorothiolate, QoI) (Hollomon & Wheeler, 2002;McGrath, 2001McGrath, , 2006. On the other hand, contact fungicides have 1a 1b low potential for resistance development because they are multi-site inhibitors (Kuck & Russell, 2006;McGrath, 2001); however, they are less important for controlling CPM because of their inherent lower efficacy due to inability to protect abaxial surfaces.…”